These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24839939)

  • 21. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruthenium(II) complexes as apoptosis inducers by stabilizing c-myc G-quadruplex DNA.
    Zhang Z; Wu Q; Wu XH; Sun FY; Chen LM; Chen JC; Yang SL; Mei WJ
    Eur J Med Chem; 2014 Jun; 80():316-24. PubMed ID: 24793882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.
    Yang L; Zhang J; Wang C; Qin X; Yu Q; Zhou Y; Liu J
    Metallomics; 2014 Mar; 6(3):518-31. PubMed ID: 24336978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor.
    Qin QP; Meng T; Tan MX; Liu YC; Luo XJ; Zou BQ; Liang H
    Eur J Med Chem; 2018 Jan; 143():1597-1603. PubMed ID: 29133054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis of structure-activity relationships between salphen metal complexes and human telomeric DNA quadruplexes.
    Campbell NH; Karim NH; Parkinson GN; Gunaratnam M; Petrucci V; Todd AK; Vilar R; Neidle S
    J Med Chem; 2012 Jan; 55(1):209-22. PubMed ID: 22112241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trizbenzim, Cu-Trizbenzim and Zn-Trizbenzim as G-Quadruplex Inducing and Stabilizing Compounds on Human Telomeric Sequence and their Anticancer Properties.
    Renuga D; Maheswari PU; Begum KMMS; Prabaharan D
    Anticancer Agents Med Chem; 2021; 21(17):2407-2418. PubMed ID: 33463477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction with DNA and different effect on the nucleus of cancer cells for copper(II) complexes of N-benzyl di(pyridylmethyl)amine.
    Chen QY; Fu HJ; Zhu WH; Qi Y; Ma ZP; Zhao KD; Gao J
    Dalton Trans; 2011 May; 40(17):4414-20. PubMed ID: 21399811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies.
    Tabassum S; Zaki M; Ahmad M; Afzal M; Srivastav S; Srikrishna S; Arjmand F
    Eur J Med Chem; 2014 Aug; 83():141-54. PubMed ID: 24953031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two novel chiral tetranucleate copper-based complexes: crystal structures, nanoparticles, and inhibiting angiogenesis and the growth of human breast cancer by regulating the VEGF/VEGFR2 signal pathway in vitro.
    Zhang PL; Hou XX; Liu MR; Huang FP; Qin XY
    Dalton Trans; 2020 May; 49(18):6043-6055. PubMed ID: 32319484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212.
    Gutiérrez AG; Vázquez-Aguirre A; García-Ramos JC; Flores-Alamo M; Hernández-Lemus E; Ruiz-Azuara L; Mejía C
    J Inorg Biochem; 2013 Sep; 126():17-25. PubMed ID: 23727332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dinuclear Cu(I) complexes of pyridyl-diazadiphosphetidines and aminobis(phosphonite) ligands: synthesis, structural studies and antiproliferative activity towards human cervical, colon carcinoma and breast cancer cells.
    Rashid A; Ananthnag GS; Naik S; Mague JT; Panda D; Balakrishna MS
    Dalton Trans; 2014 Aug; 43(29):11339-51. PubMed ID: 24922341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and crystal structure elucidation of new copper(II)-based chemotherapeutic agent coupled with 1,2-DACH and orthovanillin: Validated by in vitro DNA/HSA binding profile and pBR322 cleavage pathway.
    Zaki M; Afzal M; Ahmad M; Tabassum S
    J Photochem Photobiol B; 2016 Aug; 161():318-27. PubMed ID: 27289445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
    Cheng YF; Lu XM; Wang G
    Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic property, DFT calculation, and biological activity of bis[(μ(2)-chloro)chloro(1,10-phenanthroline)copper(II)] complex.
    Mroueh M; Daher C; Hariri E; Demirdjian S; Isber S; Choi ES; Mirtamizdoust B; Hammud HH
    Chem Biol Interact; 2015 Apr; 231():53-60. PubMed ID: 25753321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain.
    Gou Y; Qi J; Ajayi JP; Zhang Y; Zhou Z; Wu X; Yang F; Liang H
    Mol Pharm; 2015 Oct; 12(10):3597-609. PubMed ID: 26354410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
    Deng J; Gou Y; Chen W; Fu X; Deng H
    Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
    Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
    J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
    Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
    Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
    Yadav AA; Patel D; Wu X; Hasinoff BB
    J Inorg Biochem; 2013 Sep; 126():1-6. PubMed ID: 23707906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.